A REVIEW OF SODIUM PENTOBARBITAL (NAP)

pentobarbital decreases effects of sufentanil SL by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Intently. Coadministration of CYP3A4 inducers may possibly decrease sufentanil degrees and efficacy, quite possibly precipitating withdrawal syndrome in individuals who may have designed Bodily dependence to sufent